Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
efavirenz (sustiva) (2 trials)
lamivudine (epivir) (4 trials)
tenofovir (viread) (4 trials)
abacavir (ziagen) (1 trial)
dolutegravir (tivicay) (1 trial)
emtricitabine (emtriva) (3 trials)
maraviroc (selzentry) (2 trials)
nevirapine (viramune) (1 trial)
stavudine (zerit) (1 trial)
zidovudine (retrovir) (2 trials)
aidsvax b/e (1 trial)
darunavir (prezista) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
n803 (1 trial)
phis-hiv-ae (1 trial)
recombinant fowlpox virus (1 trial)
vorinostat (zolinza) (1 trial)
telmisartan (micardis) (1 trial)
Cyproterone (Androcur) (1 trial)
estradiol (progynon depot) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Communicable Diseases (Phase 3)
HIV Infections (Phase 3)
Infections (Phase 3)
Tuberculosis (Phase 4)
Trials (12 total)
Trial APIs (22 total)